Mitch McConnell’s Team Fuels Health Mystery With Cryptic Update - Yahoo News Canada

Austin Manchester is a writer and editor living in New York City. At Polygon, he covers gaming and entertainment news, reviews new video games, interviews behind-the-scenes talent, and more. He enjoys discovering hidden gems and sharing them with Polygon's audience. Previously, he was the gaming editor for AIPT Comics and has written for other outlets like XDA, How-To Geek, and The List. He enjoys soulslikes, character-driven RPGs, and third-person shooters plucked straight out of the Xbox 360 era. He also likes to flex his non-video game nerdy knowledge sometimes, whether that's explaining who's who in the new Wolverine game or recommending a comic book series about a sentient sword.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.